Hoth Therapeutics Announces $2M Direct Offering At $0.70/Shr

Hoth Therapeutics, Inc. has announced a definitive agreement for a direct offering of 2,857,144 shares of common stock at $0.70 per share, aiming to raise approximately $2 million in gross proceeds. In a concurrent private placement, the company also issued unregistered warrants for the purchase of the same number of shares at an exercise price of $0.85, potentially adding another $2.4 million if fully exercised. The offering is expected to close around April 2, 2026, subject to customary conditions, with proceeds intended for general corporate purposes, including working capital.